A case of cardiac tamponade in a synthetic cannabinoid user raises questions about cardiovascular risk

A case of cardiac tamponade (fluid compression of the heart) was reported in a person who tested positive for synthetic cannabinoids, adding to growing evidence of serious cardiovascular toxicity from these substances.

Anzillotti, Luca et al.·Legal medicine (Tokyo·2019·Preliminary EvidenceCase Report
RTHC-01915Case ReportPreliminary Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

The report documents a cardiac tamponade case with toxicology positive for synthetic cannabinoids. The authors reviewed evidence that synthetic cannabinoids can affect the cardiovascular system through multiple mechanisms including hypotension, bradycardia, myocardial infarction, arrhythmias, and interference with platelet aggregation.

Key Numbers

Toxicology was positive for synthetic cannabinoids. Known SC cardiovascular effects include: hypotension, bradycardia, myocardial infarction, atrial fibrillation, prolonged QTc, and Mobitz type II atrioventricular block.

How They Did This

Single case report with toxicological analysis and literature review of synthetic cannabinoid cardiovascular effects.

Why This Research Matters

Cardiac tamponade is a life-threatening emergency that has not been widely associated with synthetic cannabinoid use. This case expands the known range of cardiovascular complications and highlights the importance of toxicology testing for novel psychoactive substances.

The Bigger Picture

Each new cardiovascular complication reported with synthetic cannabinoids reinforces how different these substances are from natural cannabis. The variety of cardiac effects suggests multiple mechanisms of cardiovascular toxicity.

What This Study Doesn't Tell Us

A single case report cannot establish causation. Other contributing factors to the cardiac tamponade may have been present. The specific synthetic cannabinoid compound was not identified.

Questions This Raises

  • ?What is the mechanism by which synthetic cannabinoids could cause cardiac tamponade?
  • ?Is this a direct drug effect or related to secondary inflammation?
  • ?How common are severe cardiovascular events among regular SC users?

Trust & Context

Key Stat:
Cardiac tamponade reported
Evidence Grade:
Rated preliminary because this is a single case report without ability to establish causation.
Study Age:
Published in 2019.
Original Title:
A case report positive for synthetic cannabinoids: are cardiovascular effects related to their protracted use?
Published In:
Legal medicine (Tokyo, Japan), 41, 101637 (2019)
Database ID:
RTHC-01915

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Frequently Asked Questions

What is cardiac tamponade?

A life-threatening condition where fluid accumulates around the heart, compressing it and preventing it from pumping effectively. It requires emergency treatment.

Can synthetic cannabinoids cause heart problems?

Growing evidence links them to multiple cardiovascular complications including heart attacks, dangerous arrhythmias, and now potentially cardiac tamponade, though this last association is based on a single case.

Read More on RethinkTHC

Cite This Study

RTHC-01915·https://rethinkthc.com/research/RTHC-01915

APA

Anzillotti, Luca; Marezza, Francesca; Calò, Luca; Banchini, Antonio; Cecchi, Rossana. (2019). A case report positive for synthetic cannabinoids: are cardiovascular effects related to their protracted use?. Legal medicine (Tokyo, Japan), 41, 101637. https://doi.org/10.1016/j.legalmed.2019.101637

MLA

Anzillotti, Luca, et al. "A case report positive for synthetic cannabinoids: are cardiovascular effects related to their protracted use?." Legal medicine (Tokyo, 2019. https://doi.org/10.1016/j.legalmed.2019.101637

RethinkTHC

RethinkTHC Research Database. "A case report positive for synthetic cannabinoids: are cardi..." RTHC-01915. Retrieved from https://rethinkthc.com/research/anzillotti-2019-a-case-report-positive

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.